Sunwave Health Achieves ONC Health IT Certification, Strengthening Its Commitment to Behavioral Health Providers
Google Cloud Announced as a Key Technology Partner for Odoo Connect 2025 in San Francisco
Walrus and Veea Inc. Announce Strategic Partnership to Unlock High-Performance Edge Utility for Decentralized Data Storage
CWE held ‘Lancang Mekong Green Course’ Open Day to celebrate the 10th anniversary of the Nam Ngiep 2 Hydropower Station
Ultraman Omega joins the battlefield alongside beloved Ultraman Arc in Tsuburaya Production’s new Starter Deck 03 ‘Ω to the Future’ and Booster Pack 4 ‘Gleam of Eternal Hope’
SNOHOMISH, WA / ACCESSWIRE / November 1, 2021 / Nilam Resources, Inc. (OTC PINK:NILA) $NILA…
VANCOUVER, BC / ACCESSWIRE / November 1, 2021 / Commerce Resources Corp. (TSXV:CCE)(FSE:D7H0)(OTCQX:CMRZF) (the “Company”…
VANCOUVER, BC / ACCESSWIRE / November 1, 2021 / Saville Resources Inc. (TSXV:SRE)(FRA:S0J) (the “Company”…
VANCOUVER, BC / ACCESSWIRE / November 1, 2021 / Fission Uranium 3.0 (“Fission 3.0 Corp”…
TORONTO, ON / ACCESSWIRE / November 1, 2021 / Eco (Atlantic) Oil & Gas Ltd….
BLOCK LISTING SIX MONTHLY RETURN WOKINGHAM, UK / ACCESSWIRE / November 1, 2021 / Date:…
‘A Matter of Time: The Hoptroff Annual Timing Review’ looks at the past, present and future of time,…
Partnership will streamline open-ended feedback using artificial intelligence to drive better-informed decisions NEW YORK and…
ZUG, Switzerland, Nov. 01, 2021 (GLOBE NEWSWIRE) — Covis Pharma Group (“Covis”), a global specialty…
LONDON and RALEIGH, N.C., Nov. 01, 2021 (GLOBE NEWSWIRE) — Verona Pharma plc (Nasdaq: VRNA)…
Press Release 01 November 2021 Immunicum to Participate in Multiple Upcoming Industry and Investor…
Montrouge, France, November 1, 2021 DBV Technologies to Highlight New Long-term Data from REALISE Trial…
Saint-Herblain (France), November 1, 2021 – Valneva SE, a specialty vaccine company, announced today that…
Hyloris to receive $1 million milestone payment Maxigesic® IV has the potential to combat the…
Ad hoc announcement pursuant to Art. 53 LR Cenerimod 4 mg showed clinically meaningful improvement…
Geneva, Switzerland, November 1, 2021 – Addex Therapeutics (SIX: ADXN, Nasdaq: ADXN), a clinical-stage pharmaceutical…
— Follows multiple global studies of savolitinib in papillary renal cell carcinoma patients including SAVOIR and…
SHANGHAI, China and PRINCETON, N.J., Oct. 31, 2021 (GLOBE NEWSWIRE) — LianBio, a biotechnology company…
Orphazyme A/SCompany announcement No. 24/2021Inside informationCompany Registration No. 32266355 Progress made in understanding potential resolution of…
First launch in UK CAMBRIDGE, United Kingdom, Nov. 01, 2021 (GLOBE NEWSWIRE) — Bango (AIM:…